Business Description
Twist Bioscience Corp
NAICS : 339112
SIC : 8099
ISIN : US90184D1000
Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.25 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.48 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 9.21 | |||||
| Beneish M-Score | -3.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.3 | |||||
| 3-Year EBITDA Growth Rate | -0.7 | |||||
| 3-Year EPS without NRI Growth Rate | 3.7 | |||||
| 3-Year FCF Growth Rate | 25.5 | |||||
| 3-Year Book Growth Rate | -11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 26.42 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.69 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.13 | |||||
| 9-Day RSI | 57.35 | |||||
| 14-Day RSI | 56.12 | |||||
| 6-1 Month Momentum % | 1.02 | |||||
| 12-1 Month Momentum % | 21.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.88 | |||||
| Quick Ratio | 4.54 | |||||
| Cash Ratio | 3.89 | |||||
| Days Inventory | 59.28 | |||||
| Days Sales Outstanding | 42.52 | |||||
| Days Payable | 15.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | 0.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.61 | |||||
| Operating Margin % | -56.2 | |||||
| Net Margin % | -66.69 | |||||
| FCF Margin % | -22.07 | |||||
| ROE % | -38.12 | |||||
| ROA % | -30.12 | |||||
| ROIC % | -48.02 | |||||
| ROC (Joel Greenblatt) % | -101.65 | |||||
| ROCE % | -33.42 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.93 | |||||
| PB Ratio | 6 | |||||
| Price-to-Tangible-Book | 7.61 | |||||
| EV-to-EBIT | -12.82 | |||||
| EV-to-EBITDA | -15.1 | |||||
| EV-to-Revenue | 8.52 | |||||
| EV-to-FCF | -38.56 | |||||
| Price-to-Net-Current-Asset-Value | 13.86 | |||||
| Price-to-Net-Cash | 21 | |||||
| Earnings Yield (Greenblatt) % | -7.8 | |||||
| FCF Yield % | -2.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Twist Bioscience Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 286.846 | ||
| EPS (TTM) (€) | -3.313 | ||
| Beta | 2.01 | ||
| Volatility % | 77.41 | ||
| 14-Day RSI | 56.12 | ||
| 14-Day ATR (€) | 1.599538 | ||
| 20-Day SMA (€) | 46.0315 | ||
| 12-1 Month Momentum % | 21.11 | ||
| 52-Week Range (€) | 25.78 - 53.2 | ||
| Shares Outstanding (Mil) | 59.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Twist Bioscience Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Twist Bioscience Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Twist Bioscience Corp Frequently Asked Questions
What is Twist Bioscience Corp(FRA:0ME)'s stock price today?
The current price of FRA:0ME is €46.42. The 52 week high of FRA:0ME is €53.20 and 52 week low is €25.78.
When is next earnings date of Twist Bioscience Corp(FRA:0ME)?
The next earnings date of Twist Bioscience Corp(FRA:0ME) is 2025-01-31 Est..
Does Twist Bioscience Corp(FRA:0ME) pay dividends? If so, how much?
Twist Bioscience Corp(FRA:0ME) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers